The Public Health Consequences of Performance-Enhancing Substances: Who Bears Responsibility?

doi:10.1001/jama.2017.17111

Editorial

. 2017 Nov 28;318(20):1983-1984.

doi: 10.1001/jama.2017.17111.

The Public Health Consequences of Performance-Enhancing Substances: Who Bears Responsibility?

Richard J Auchus^{1

2}, Kirk J Brower³

Affiliations

¹ Division of Metabolism, Diabetes, and Endocrinology, Department of Internal Medicine, University of Michigan, Ann Arbor.
² Department of Pharmacology, University of Michigan, Ann Arbor.
³ Department of Psychiatry and Addiction Research Center, University of Michigan, Ann Arbor.

PMID: 29183050
DOI: 10.1001/jama.2017.17111

Editorial

The Public Health Consequences of Performance-Enhancing Substances: Who Bears Responsibility?

Richard J Auchus et al. JAMA. 2017.

. 2017 Nov 28;318(20):1983-1984.

doi: 10.1001/jama.2017.17111.

Authors

Richard J Auchus^{1

2}, Kirk J Brower³

Affiliations

¹ Division of Metabolism, Diabetes, and Endocrinology, Department of Internal Medicine, University of Michigan, Ann Arbor.
² Department of Pharmacology, University of Michigan, Ann Arbor.
³ Department of Psychiatry and Addiction Research Center, University of Michigan, Ann Arbor.

PMID: 29183050
DOI: 10.1001/jama.2017.17111

No abstract available

PubMed Disclaimer

Comment on

Chemical Composition and Labeling of Substances Marketed as Selective Androgen Receptor Modulators and Sold via the Internet.
Van Wagoner RM, Eichner A, Bhasin S, Deuster PA, Eichner D. Van Wagoner RM, et al. JAMA. 2017 Nov 28;318(20):2004-2010. doi: 10.1001/jama.2017.17069. JAMA. 2017. PMID: 29183075 Free PMC article.

Cited by

Could Overt Diabetes Be Triggered by Abuse of Selective Androgen Receptor Modulators and Growth Hormone Secretagogues? A Case Report and Review of the Literature.
Sotorník R, Suissa R, Ardilouze JL. Sotorník R, et al. Clin Diabetes. 2022 Summer;40(3):373-379. doi: 10.2337/cd21-0044. Clin Diabetes. 2022. PMID: 35983415 Free PMC article. No abstract available.
Liver injury associated with the use of selective androgen receptor modulators and post-cycle therapy: Two case reports and literature review.
Koller T, Vrbova P, Meciarova I, Molcan P, Smitka M, Adamcova Selcanova S, Skladany L. Koller T, et al. World J Clin Cases. 2021 Jun 6;9(16):4062-4071. doi: 10.12998/wjcc.v9.i16.4062. World J Clin Cases. 2021. PMID: 34141767 Free PMC article.
Treatments for people who use anabolic androgenic steroids: a scoping review.
Bates G, Van Hout MC, Teck JTW, McVeigh J. Bates G, et al. Harm Reduct J. 2019 Dec 30;16(1):75. doi: 10.1186/s12954-019-0343-1. Harm Reduct J. 2019. PMID: 31888665 Free PMC article. Review.
Performance-Enhancing Drugs Abuse Caused Cardiomyopathy and Acute Hepatic Injury in a Young Bodybuilder.
Li C, Adhikari BK, Gao L, Zhang S, Liu Q, Wang Y, Sun J. Li C, et al. Am J Mens Health. 2018 Sep;12(5):1700-1704. doi: 10.1177/1557988318783504. Epub 2018 Jun 21. Am J Mens Health. 2018. PMID: 29926766 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The Public Health Consequences of Performance-Enhancing Substances: Who Bears Responsibility?

Affiliations

The Public Health Consequences of Performance-Enhancing Substances: Who Bears Responsibility?

Authors

Affiliations

Comment on

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources